"Composition of the gut microbiota in patients with COVID-19 is concordant with disease severity and magnitude of plasma concentrations of several inflammatory cytokines, chemokines and blood markers of tissue damage."
gut.bmj.com/content/early/…
gut.bmj.com/content/early/…
"Patients with COVID-19 were depleted in gut bacteria with known immunomodulatory potential, such as Faecalibacterium prausnitzii, Eubacterium rectale and several bifidobacterial species."
"The dysbiotic gut microbiota that persists after disease resolution could be a factor in developing persistent symptoms and/or multisystem inflammation syndromes that occur in some patients after clearing the virus."
"Bolstering of beneficial gut species depleted in COVID-19 could serve as a novel avenue to mitigate severe disease, underscoring importance of managing patients’ gut microbiota during and after COVID-19"
• • •
Missing some Tweet in this thread? You can try to
force a refresh
